Table 1.
Baseline characteristics of participants.
| Placebo (n = 14) | Synbiotic (n = 13) | All (n = 27) | |
|---|---|---|---|
| Women/men N (%) | 12/2 (86/14) | 11/2 (85/15) | 23/4 (85/14) |
| Age (years old) | 58 ± 7 | 58 ± 5 | 58 ± 6 |
| Body weight (kg) | 64.5 ± 11.4 | 69.1 ± 10.9 | 66.7 ± 11.2 |
| BMI (kg/m2) | 23.8 ± 3.2 | 24.7 ± 3.4 | 24.3 ± 3.3 |
| SBP (mm Hg) | 118.2 ± 15.8 | 118.2 ± 18.3 | 118.5 ± 16.7 |
| DBP (mm Hg) | 73.6 ± 6.6 | 75.8 ± 9.1 | 74.6 ± 7.8 |
| ALAT (UI/l) | 19.4 ± 6.1 | 24.8 ± 8.6 | 22.0 ± 7.7 |
| ASAT (UI/l) | 21.6 ± 4.2 | 24.1 ± 5.5 | 22.8 ± 4.9 |
| Glycemia (g/l) | 0.93 ± 0.10 | 0.97 ± 0.10 | 0.95 ± 0.10 |
| Triglyceridemia (g/l) | 0.96 ± 0.37 | 0.98 ± 0.43 | 0.97 ± 0.39 |
| Cholesterolemia (g/l) | 2.35 ± 0.40 | 2.38 ± 0.38 | 2.37 ± 0.39 |
Values are means ± SD. Baseline data were analyzed by Mann–Whitney test for continuous variables (p > 0.05) and Fisher test for categorical variables (ratio women/men; p > 0.05).
ALAT alanine aminotransferase, ASAT aspartate aminotransferase, BMI body mass index, DBP diastolic blood pressure, SBP systolic blood pressure.